Acta Med. 1997, 40: 89-94

Differential Inhibition of the Brain Acetylcholinesterase Molecular Forms Following Sarin, Soman and VX Intoxication in Laboratory Rats

Jiří Bajgar

Military Medical Academy Hradec Králové, 500 01 Hradec Králové, Czech Republic

Received October 1, 1997
Accepted November 1, 1997


1. Andersen RA, Aaraas I, Gaare G, Fonnum F. Inhibition of acetylcholinesterase from different species by organophosphorus compounds, carbamates and methylsulphonylfluoride. Gen Pharmacol 1977; 8:331-4. <>
2. Bajgar J, Žižkovský V. Partial characterization of soluble acetylcholinesterase isoenzymes of the rat brain. J Neurochem 1971; 18:1609-14. <>
3. Bajgar J, Pařízek J. Changes of acetylcholinesterase and esterase isoenzymes in isolated cerebellar cortex of the rabbit. Brain Res 1973; 57:299-305. <>
4. Bajgar J. Characterization and properties of multiple molecular forms of acetylcholinesterase. Possible evaluation in histochemistry. Acta Histochem 1975; 15(Suppl.):123-32.
5. Bajgar J. Isoenzymes of rat brain acetylcholinesterase: facts or artifacts? J Neurochem 1979; 32:1875-9. <>
6. Bajgar J. Intoxikace organofosforovými inhibitory cholinesteráz - účinek, diagnóza a terapie. 1st ed. Avicenum: Praha 1985:7-40.
7. Bajgar J. The influence of inhibitors and other factors on cholinesterases. Sb Ved Pr Lek Fak Karlovy University Hradec Králové 1991; 34:3-75.
8. Bajgar J. Biological monitoring of exposure to nerve agents. Brit J Ind Med 1992; 49:648-53.
9. Bajgar J, Kassa J, Krs O, Fusek J. Inhibition of rabbit erythrocyte acetylcholinesterase by soman. 5th International Symposium on Protection against CBWA. Stockholm, Sweden, 11-16 June 1995.
10. Bajgar J, Michalek H, Bisso GM. Differential inhibition of rat brain acetylcholinesterase molecular forms by 7-methoxytacrine in vitro. Toxicol Lett 1995; 80:109-14. <>
11. Bajgar J, Michalek H, Bisso GM. Differential reactivation by HI-6 in vivo of Paraoxon-inhibited rat brain acetylcholinesterase molecular forms. Neurochem Int 1995; 26:347-50. <>
12. Brimijoin S, Rakonczay Z. Immunocytology and molecular histology of cholinesterases: current results and prospects. Int Rev Neurobiol 1986; 28:353-410.
13. Brownson RH, Mc Dougal HD, Suter BD, Vijayan VK. Parathion-induced alterations in chemical, biochemical and isoenzyme study. In: Neurotoxicology (L. Roizin, H. Shirachi and N. Grcevic, Eds.), New York, Raven Press, 1977:457-68.
14. Buccafusco JJ, Graham JH, VanLingen J, Aronstam RS. Protection afforded by clonidine from the acute and chronic behavioral toxicity produced by the cholinesterase inhibitor soman. Neurotoxicol Teratol 1989; 11:39-44. <>
15. Clement JG. Survivors of soman poisoning: recovery of the soman LD50 to control value in the presence of extensive acetylcholinesterase inhibition. Arch Toxicol 1989; 63: 150-4. <>
16. Clement JG, Hand BT, Shilhoff JD. Differences in the toxicity of soman in various strains of mice. Fund Appl Toxicol 1981; 1:419-20. <>
17. Dawson RM. Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol 1994; 14:317-31. <>
18. Ellman GL, Courtney DK, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7:88-95. <>
19. FOA report: Fifth International Symposium on Protection against Chemical Warfare Agents. Proceedings, B 95-00122-4.9-SE, Stockholm-Umea, 1995:1-436.
20. Freeman SE, Dawson RM. Tacrine: a pharmacological review. Prog Neurobiol 1991; 36:257-77. <>
21. Jokanovic M. Liver esterases and soman toxicity in the rat following partial hepatectomy. Biochem Pharmacol 1990; 39:797-9. <>
22. Kadar T, Raveh L, Cohen G et al. Distribution of 3Hsoman in mice. Arch Toxicol 1985; 58:45-9. <>
23. Kaliste-Korhonen E, Ryhanen R, Ylitalo P, Hanninen O. Cold exposure decreases the effectiveness of atropineoxime treatment in organophosphate intoxication in rats and mice. Gen Pharmacol 1989; 20:805-9. <>
24. Kovačevič V, Maksimovič M. Protective effects of mixture of oximes in poisoning by nerve chemical warfare agents. Acta Pharm Yugoslav 1991; 41:75-8.
25. Lenz DE, Maxwell DM. Inhibition of rat cerebrum acetylcholinesterase isoenzymes after acute administration of soman. Biochem Pharmacol 1981; 30:1369-71. <>
26. Little PJ, Scimeca JA, Martin BR. Distribution of /H3/diisopropylfluorophosphate, /H3/soman, /H3/sarin, and their metabolites in mouse brain. Drug Metab Disp 1988; 16: 515-20.
27. Maekawa K. The sarin poisoning incident in Tokyo subway. PÞednáška na The Fifth International Symposium on Protection Against CBWA, Stockholm, June 11-16, 1995.
28. Marrs TC, Maynard RL, Sidell FR. Chemical warfare agents. Toxicology and treatment. J. Wiley and Sons. Chicester, New York, Brisbane,Toronto,Singapore, 1996:1-243.
29. Maxwell DM, Brecht KM. The role of carboxylesterase in species variation of oxime protection against soman. Neurosci Biobehav Rev 1991; 15:135-9. <>
30. Michalek H, Meneguz A, Bisso GM. Molecular forms of rat brain acetylcholinesterase in DFP intoxication and subsequent recovery. Neurobehav Toxicol Terratol 1981; 3:303-12.
31. Ogane N, Giacobini E, Messamore E. Preferential inhibition of acetylcholinesterase molecular forms in rat brain. J Neurochem 1992; 17:489-95. <>
32. Patočka J, Bajgar J, Bielavský J, Fusek J. Kinetics of inhibition of cholinesterase by 1,2,3, 4-tetrahydro-9-aminoacridine. Collect Czech Chem Commun 1976; 41:816-24. <>
33. Rakonczay Z. Cholinesterase and its molecular forms in pathological states. Progr Neurobiol 1988; 31:311-30. <>
34. Shapira S, Kadar T, Cohen G, Chapman S, Raveh L. Effets of CBDP and MEPQ on the toxicity and distribution of /H3/-somanin mice. Arch Toxicol 1990; 64:663-8. <>
35. Shih TM, Penetar DM, McDonough JH, Romano JA, King JM. Age-related differences in soman toxicity and in blood and regional cholinesterase activity. Brain Res Bull 1990; 24:429-36. <>
36. Skau KA. Mammalian acetylcholinesterase:molecular forms. Comp Biochem Physiol 1986; 83C:225-7.
37. Skopec F, Bajgar J. Anticholinesterase action of organophosphates: importance of the liver. Sb Ved Pr Lek Fak Karlovy Univerzity Hradec Králové 1993; 36:83-92.
38. Soreq H, Gnatt A, Loewenstein Y, Neville LF. Excavations into the active site-gorge of cholinesterase. TIBS 1992; 17:353-8.
39. Taylor P. Anticholinesterase agents. In: Gilman AG, Goodman LS, Rall TW and Murad F (Eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics, 7th ed. MacMillan, New York, 1985:1-129.
40. Traina ME, Serpietri LA. Changes in the levels and form of rat plasma cholinesterases during chronic diisopropylphosphorofluoridate intoxication. Biochem Pharmacol 1984; 33:645-53. <>
41. Uhlig M, Luppa H. Charakterisierung esterspaltender Enzyme des Gehirns mit Hilfe der Polyacrylamid-Gel- Elektrophorese. Acta histochem 1975; 15(Suppl.):133-7.
42. Vachek J, Geräl V, Fusek J, Krs O, Skopec F, Bajgar J. Toxicities of O-alkyl S-(2-dialkylaminoethyl) methyl phosphonothiolates (V-compounds). Acta Medica (Hradec Králové) 1996; 39:67-71.
43. Volpe MT, Bisso GM, Michalek H. In vivo and in vitro effects of diisopropyl fluorophosphate and paraoxon on individual molecular forms of rats brain acetylcholinesterase. Neurochem Res 1990; 15:975-80. <>
44. Yanagisawa N. A medical survey of patients from the "organophosphorus poison gas (sarin) poisoning" of 27 June 1994 examined at hospitals in Matsumoto City. Japan Non-paper for discussion, Second Meeting of the Task Force on Medical Treatment (Haag, 2.-5.5.1995).
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal